Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Source study found

Story checked

This popular fermented food may help flush nanoplastics from the body | ScienceDaily (opens in a new tab)

sciencedaily.com · 2026-09-17

Short answerEvidenceSource

Short answer

Mostly not supported

Mostly not supported.

One claim goes further than the study. 4 other points were not covered by the paper.

  • 2 supported
  • 1 overstated
  • 4 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mostly not supported

One claim overstates the study. Two of seven check out. Four claims the study doesn't address.

  • 2 supported
  • 1 overstated
  • 4 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

7 claims in this story

Showing all 7 claimsChoose a verdict to focus the list.

Claim 1 of 7OverstatedThe World Institute of Kimchi announced that a lactic acid bacterium isolated from kimchi can help promote the removal of nanoplastics from the body by binding to them in the intestine.View evidenceHide evidence

Why this verdict

The paper profile supports intestinal-relevant biosorption and enhanced fecal NP excretion in vivo, but the story frames this as an unhedged causal claim that the bacterium 'can' promote removal 'from the body' by binding in the intestine. At abstract depth, the in vivo model, dosing, comparator, quantitative effect size, and direct in-intestine binding mechanism are not specified, so the claim outruns the evidence.

1

Study evidence

Under simulated intestinal fluid, Leuconostoc mesenteroides strain CBA3656 outperformed other L. mesenteroides strains in NP biosorption (abstract statement).

“Under simulated intestinal fluid, strain CBA3656 outperformed other Leuconostoc mesenteroides strains”
2

Study evidence

Administration of Leuconostoc mesenteroides CBA3656 was associated with significantly increased fecal excretion of nanoplastics in vivo (statement reported in abstract).

“in vivo experiments demonstrated significantly enhanced fecal excretion of NPs.”
Claim 2 of 7Not coveredResearchers investigated the adsorption capacity of Leuconostoc mesenteroides CBA3656 against polystyrene nanoplastics.View evidenceHide evidence

Why this verdict

The profile supports that researchers studied NP adsorption/biosorption capacity of Leuconostoc mesenteroides CBA3656. However, the abstract-level profile does not specify that the nanoplastics were polystyrene, so that material detail cannot be verified at this evidence depth.

1

Study evidence

Leuconostoc mesenteroides CBA3656 exhibited high nanoplastic biosorption efficiency across NP concentrations 10–200 ppm, pH 3–9, and temperatures 4–55°C.

“Leuconostoc mesenteroides CBA3656 exhibited high NP biosorption efficiency across a wide range of NP concentrations (10-200 ppm), pH values (3-9), and temperatures (4-55°C), along with rapid adsorption at short contact times.”
Claim 3 of 7Not coveredUnder standard laboratory conditions, strain CBA3656 showed an adsorption efficiency of 87%, comparable to the reference strain Latilactobacillus sakei CBA3608 at 85%.View evidenceHide evidence

As stated87% and 85%

Why this verdict

The abstract-level profile says CBA3656 showed high NP biosorption efficiency, but it explicitly lacks numerical adsorption percentages and does not report the 87% value, the 85% reference value, or the named reference strain CBA3608. These quantitative details cannot be verified from the supplied abstract profile.

1

Study evidence

Leuconostoc mesenteroides CBA3656 exhibited high nanoplastic biosorption efficiency across NP concentrations 10–200 ppm, pH 3–9, and temperatures 4–55°C.

“Leuconostoc mesenteroides CBA3656 exhibited high NP biosorption efficiency across a wide range of NP concentrations (10-200 ppm), pH values (3-9), and temperatures (4-55°C), along with rapid adsorption at short contact times.”
Claim 4 of 7Not coveredUnder simulated human intestinal conditions, CBA3656 maintained an adsorption level of 57%, while CBA3608 decreased sharply to 3%.View evidenceHide evidence

As stated57% versus 3%

Why this verdict

The profile supports the general finding that CBA3656 outperformed other L. mesenteroides strains under simulated intestinal fluid, but it does not report the stated 57% versus 3% values or the CBA3608 comparator detail. Therefore the specific magnitude and comparator cannot be verified at abstract depth.

1

Study evidence

Under simulated intestinal fluid, Leuconostoc mesenteroides strain CBA3656 outperformed other L. mesenteroides strains in NP biosorption (abstract statement).

“Under simulated intestinal fluid, strain CBA3656 outperformed other Leuconostoc mesenteroides strains”
Claim 5 of 7Not coveredIn germ-free mice, both male and female mice given strain CBA3656 had more than a twofold increase in nanoplastics detected in feces compared with controls.View evidenceHide evidence

As statedmore than a twofold increase

Why this verdict

The abstract-level profile supports a general in vivo finding of significantly enhanced fecal NP excretion after CBA3656 administration. It does not specify germ-free mice, male and female subgroup results, controls, or a more-than-twofold magnitude, so the story's specific animal-model and effect-size details are not verifiable at this depth.

1

Study evidence

Administration of Leuconostoc mesenteroides CBA3656 was associated with significantly increased fecal excretion of nanoplastics in vivo (statement reported in abstract).

“in vivo experiments demonstrated significantly enhanced fecal excretion of NPs.”
Claim 6 of 7SupportedA bacterium found in kimchi may help trap nanoplastics in the gut and boost their removal from the body.View evidenceHide evidence

Why this verdict

The abstract-level profile supports a hedged headline claim: CBA3656 outperformed other strains under simulated intestinal fluid and in vivo experiments showed significantly enhanced fecal excretion of nanoplastics. Because the claim says 'may help' rather than asserting proven human benefit, it is aligned with the evidence at this depth.

1

Study evidence

Under simulated intestinal fluid, Leuconostoc mesenteroides strain CBA3656 outperformed other L. mesenteroides strains in NP biosorption (abstract statement).

“Under simulated intestinal fluid, strain CBA3656 outperformed other Leuconostoc mesenteroides strains”
2

Study evidence

Administration of Leuconostoc mesenteroides CBA3656 was associated with significantly increased fecal excretion of nanoplastics in vivo (statement reported in abstract).

“in vivo experiments demonstrated significantly enhanced fecal excretion of NPs.”
Claim 7 of 7SupportedThe study suggests kimchi-derived lactic acid bacteria may interact with environmental micropollutants beyond their traditional role in fermentation and may help reduce nanoplastic accumulation in the gastrointestinal tract.View evidenceHide evidence

Why this verdict

The paper profile supports a hedged interpretation that kimchi/food-derived lactic acid bacteria can interact with nanoplastics and may be promising microbial biosorbents under environmental and intestinal-relevant conditions. The claim is speculative and does not state proven human benefit, so it is supported at the abstract level.

1

Study evidence

Leuconostoc mesenteroides CBA3656 exhibited high nanoplastic biosorption efficiency across NP concentrations 10–200 ppm, pH 3–9, and temperatures 4–55°C.

“Leuconostoc mesenteroides CBA3656 exhibited high NP biosorption efficiency across a wide range of NP concentrations (10-200 ppm), pH values (3-9), and temperatures (4-55°C), along with rapid adsorption at short contact times.”
2

Study evidence

Under simulated intestinal fluid, Leuconostoc mesenteroides strain CBA3656 outperformed other L. mesenteroides strains in NP biosorption (abstract statement).

“Under simulated intestinal fluid, strain CBA3656 outperformed other Leuconostoc mesenteroides strains”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • The paper reports kinetic and isotherm modeling, with pseudo-first-order kinetics and Langmuir isotherm behavior interpreted as predominantly physical adsorption.

    This mechanistic/modeling component is material to the paper profile but is not mentioned in the story presentation.

    From in_vitro batch biosorption assays with kinetic/isotherm modeling

  • FTIR spectroscopy implicated PO, CO, and COC functional groups in bacterial cell wall/membrane components as contributors to NP interactions.

    The story discusses binding generally but does not reflect the FTIR functional-group evidence or its indirect mechanistic role.

    From FTIR-based comparative spectral analysis

  • The abstract profile lacks key details for the in vivo study, including species/model, sample size, dosing regimen, NP characteristics, analytical method, quantitative effect size, and statistical details.

    The story caveats early-stage research and no proof of human benefit, but it does not reflect the extent of missing methodological and quantitative detail in the abstract-level evidence.

    From in vivo animal

5 things the story did carry across
  • CBA3656 was characterized for nanoplastic biosorption across concentrations, pH, temperature, and contact time, with rapid/high adsorption reported.
  • Under simulated intestinal fluid, CBA3656 outperformed comparator L. mesenteroides strains in NP biosorption.
  • In vivo experiments showed significantly enhanced fecal excretion of nanoplastics after CBA3656 administration.
  • Generalisability to humans cannot be assessed from the abstract-level in vivo evidence.
  • The paper is specifically about nanoplastics/NPs, while broader claims about environmental micropollutants are interpretive rather than directly tested beyond NP binding.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

4

Evidence read

study summary

Lead result

in vitro

1Lead resultin vitroCharacterize and quantify nanoplastic (NP) biosorption performance of food-derived Leuconostoc mesenteroides CBA3656 across environmental-relevant conditions (concentration, pH, temperature, contact time) and model the adsorption kinetics/isotherm behavior.in vitro batch biosorption assays with kinetic/isotherm modelingExpand

In plain English

In vitro batch assays show that food-derived Leuconostoc mesenteroides CBA3656 rapidly and efficiently biosorbs nanoplastics (NPs) across tested concentrations (10–200 ppm), pH (3–9), temperatures (4–55°C) and short contact times. Adsorption kinetics were reported to follow a pseudo-first-order model and equilibrium uptake fit a Langmuir isotherm, consistent with predominantly physical adsorption. FTIR analysis implicated cell surface functional groups (P–O, C=O, C–O–C) in NP interactions.

Key findings

  • Leuconostoc mesenteroides CBA3656 exhibited high nanoplastic biosorption efficiency across NP concentrations 10–200 ppm, pH 3–9, and temperatures 4–55°C.
  • CBA3656 showed rapid adsorption at short contact times.
“Leuconostoc mesenteroides CBA3656 exhibited high NP biosorption efficiency across a wide range of NP concentrations (10-200 ppm), pH values (3-9), and temperatures (4-55°C), along with rapid adsorption at short contact times.”
What this piece can’t prove

3 further details could not be confirmed from the summary.

2in vitroIdentify putative chemical/functional-group determinants of NP binding on/within bacterial cell envelope using spectroscopy to support a physical adsorption mechanism.FTIR-based comparative spectral analysisExpand

In plain English

Fourier-transform infrared spectroscopy (FTIR) was used to characterize cell envelope functional groups of Leuconostoc mesenteroides CBA3656 implicated in interactions with nanoplastics (NPs). The abstract reports involvement of PO, CO, and COC functional groups from cell wall and membrane components, consistent with a predominantly physical adsorption mechanism.

Key findings

  • FTIR spectroscopy indicated that PO, CO, and COC functional groups from cell wall and membrane components contribute to interactions between L. mesenteroides CBA3656 and nanoplastics.
“Fourier-transform infrared spectroscopy revealed that functional groups such as PO, CO, and COC in cell wall and membrane components contribute to NP interactions.”
What this piece can’t prove
  • Spectroscopy results are reported qualitatively with no quantification of spectral changes or binding contributions.
  • FTIR provides indirect evidence of group involvement and cannot definitively establish the molecular mechanism or specificity of NP binding without complementary analyses.

1 further detail could not be confirmed from the summary.

3in vitroTest whether CBA3656 functions under intestinal-relevant conditions, including simulated intestinal fluid performance vs other L. mesenteroides strains and in vivo enhancement of fecal NP excretion.Simulated intestinal fluid in vitro comparative assay; in vivo fecal excretion studyExpand

In plain English

The abstract reports that the food-derived bacterium Leuconostoc mesenteroides CBA3656 outperformed other L. mesenteroides strains in nanoplastic (NP) biosorption when assayed in simulated intestinal fluid, and that in vivo experiments with the strain led to significantly increased fecal excretion of NPs. The abstract does not provide numerical effect sizes, detailed assay conditions, or statistical details.

Key findings

  • Under simulated intestinal fluid, Leuconostoc mesenteroides strain CBA3656 outperformed other L. mesenteroides strains in NP biosorption (abstract statement).
  • In vivo experiments with strain CBA3656 resulted in significantly enhanced fecal excretion of NPs (abstract statement).
“Under simulated intestinal fluid, strain CBA3656 outperformed other Leuconostoc mesenteroides strains”
What this piece can’t prove

3 further details could not be confirmed from the summary.

4in vivo animalTest whether CBA3656 functions under intestinal-relevant conditions, including simulated intestinal fluid performance vs other L. mesenteroides strains and in vivo enhancement of fecal NP excretion.Expand

In plain English

The abstract reports an in vivo experiment in which administration of the food-derived bacterium Leuconostoc mesenteroides CBA3656 produced a statistically significant increase in fecal excretion of nanoplastics (NPs). The abstract does not provide species, dosing regimen, NP characteristics, analytical methods, sample sizes, or quantitative effect estimates for the in vivo study.

Key findings

  • Administration of Leuconostoc mesenteroides CBA3656 was associated with significantly increased fecal excretion of nanoplastics in vivo (statement reported in abstract).
“in vivo experiments demonstrated significantly enhanced fecal excretion of NPs.”
What this piece can’t prove

3 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Crossref · 23 candidate papers

And 17 more candidates considered.